Q3 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-16 | ||||||
REV |
Q2 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.580 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
KALV | KalVista Pharmaceuticals | 32.90 | 0.56 | 1.73% | 793.7M |
You can purchase shares of KalVista Pharmaceuticals (NASDAQ: KALV) through any online brokerage.
Other companies in KalVista Pharmaceuticals’s space includes: Curis (NASDAQ:CRIS), Chinook Therapeutics (NASDAQ:KDNY) and Prothena Corp (NASDAQ:PRTA).
The latest price target for KalVista Pharmaceuticals (NASDAQ: KALV) was reported by Roth Capital on 2021-02-18. The analyst firm set a price target for 55.00 expecting KALV to rise to within 12 months (a possible 67.17% upside). 6 analyst firms have reported ratings in the last year.
The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $32.9 last updated Today at 6:22:54 PM.
There are no upcoming dividends for KalVista Pharmaceuticals.
There is no upcoming split for KalVista Pharmaceuticals.